Iridex (IRIX) Cash from Investing Activities Growth (1y) (2012 - 2026)
Iridex (IRIX) Cash from Investing Activities Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 0.00% |
| 10 | Iridex | 13.40 Mn | 8.72 Mn | 4.30 Mn | -284.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -818.18% |
| Jan 3, 2026 | -1,077.78% |
| Sep 27, 2025 | -1,200.00% |
| Mar 29, 2025 | -266.67% |
| Dec 28, 2024 | -128.13% |
| Sep 28, 2024 | 98.78% |
| Mar 30, 2024 | 93.02% |
| Dec 30, 2023 | 138.55% |
| Sep 30, 2023 | -43.86% |
| Jul 1, 2023 | 86.67% |
| Apr 1, 2023 | -65.38% |
| Dec 31, 2022 | 98.48% |
| Apr 2, 2022 | 99.52% |
| Apr 3, 2021 | -7,864.71% |
| Sep 26, 2020 | 96.24% |
| Jun 27, 2020 | 92.52% |
| Mar 28, 2020 | 58.28% |
| Dec 28, 2019 | 50.75% |
| Sep 28, 2019 | 0.00% |
| Jun 29, 2019 | 24.23% |